NewsRoom Articles - Page 1111 of 1412

TuesdayMar 13, 2018 11:30 am

Cogentix Medical, Inc. (NASDAQ: CGNT) Starts Presentation at 30th Annual ROTH Conference

Cogentix Medical (NASDAQ: CGNT) is a global medical device company that designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand. The company’s innovative products provide users with efficient and cost-effective endoscope turnover while increasing patient safety. The company also commercializes the Urgent® PC Neuromodulation System, an FDA-cleared device that delivers percutaneous tibial nerve stimulation for the office-based treatment of overactive bladder (“OAB”). Additionally, the company offers Macroplastique®, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency. The company is headquartered in…

TuesdayMar 13, 2018 11:00 am

PCM, Inc. (NASDAQ: PCMI) Starts Presentation at 30th Annual ROTH Conference

PCM (NASDAQ: PCMI), through its wholly owned subsidiaries, is a multi-vendor technology solutions provider. The company’s solutions include hardware, software and services to small, medium and enterprise businesses; state, local and federal governments; and educational institutions throughout the United States, Canada and the United Kingdom. The company generated net sales of $2.2 billion in the 12 months ended September 2017. For more information, visit the company’s website at www.investor.pcm.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics…

TuesdayMar 13, 2018 11:00 am

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Starts Presentation at 30th Annual ROTH Conference

Madrigal Pharmaceuticals (NASDAQ: MDGL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need. Madrigal’s lead candidate, MGL-3196, is a first-in-class, orally administered, small-molecule, liver-directed, thyroid hormone receptor (THR) β-selective agonist that is currently in Phase 2 development for non-alcoholic steatohepatitis (NASH) and heterozygous familial hypercholesterolemia (HeFH). For more information, visit the company’s website at www.madrigalpharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides…

TuesdayMar 13, 2018 11:00 am

Adesto Technologies Corp. (NASDAQ: IOTS) Starts Presentation at 30th Annual ROTH Conference

Adesto Technologies (NASDAQ: IOTS) is a provider of application-specific, ultra-low power, smart non-volatile memory products. The company has designed and built a portfolio of innovative products with intelligent features to conserve energy and enhance performance, including Fusion Serial Flash, DataFlash®, EcoXiP™ and products based on its trademark resistive RAM technology called Conductive Bridging RAM (CBRAM®). CBRAM® is a breakthrough technology platform that enables 100 times less energy consumption than today’s flash memory technologies as well as delivering enhanced performance. For more information, visit the company’s website at www.adestotech.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company…

TuesdayMar 13, 2018 11:00 am

Genfit SA (GNFTF) Starts Presentation at 30th Annual ROTH Conference

Genfit (OTC: GNFTF) is a France-based biopharmaceutical company that specializes in the development of medicines for the prevention and treatment of diabetes and related disorders. The company’s therapeutic and diagnostic solutions address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver. Genfit provides diagnostic solutions in various therapeutic areas, such as metabolic diseases, liver diseases, non-alcoholic steato-hepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. For more information, visit the company’s website at www.genfit.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access…

TuesdayMar 13, 2018 11:00 am

Vertex Energy, Inc. (NASDAQ: VTNR) Starts Presentation at 30th Annual ROTH Conference

Vertex Energy (NASDAQ: VTNR) is a Houston, Texas-based specialty refiner of alternative feedstocks and a marketer of high-purity petroleum products. The company is one of the largest processors of used motor oil in the United States and has processing capacity of more than 115 million gallons per year. Vertex has implemented the most cost-effective strategy for building its feedstock supply by establishing a successful self-collection and aggregation system. The company has also built a reputation as a key supplier of Group II+ and Group III base oils to the lubricant manufacturing industry in North America. For more information, visit the…

TuesdayMar 13, 2018 11:00 am

Viking Therapeutics, Inc. (NASDAQ: VKTX) Starts Presentation at 30th Annual ROTH Conference

Viking Therapeutics (NASDAQ: VKTX) is a clinical-stage biopharmaceutical company engaged in developing novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. Viking’s R&D activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. The company has global rights to a portfolio of five therapeutic programs in clinical trials or preclinical studies that are based on small molecules licensed from Ligand Pharmaceuticals Incorporated. For more information, visit the company’s website at www.vikingtherapeutics.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via…

TuesdayMar 13, 2018 11:00 am

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Starts Presentation at 30th Annual ROTH Conference

Ritter Pharmaceuticals (NASDAQ: RTTR) is engaged in the development of novel therapeutics that modulate the gut microbiome to treat gastrointestinal diseases. RP-G28, the company’s lead product, has the potential to become the very first FDA-approved lactose intolerance treatment, addressing a condition that affects millions of individuals throughout the world. This product has been studied in phase 2 trials and is currently in phase 3 clinical development. Ritter Pharmaceuticals is additionally exploring the functionality and discovering the therapeutic potential of gut microbiome changes on treating and/or preventing various conditions, including gastrointestinal diseases, immuno-oncology, metabolic and liver disease. For more information, visit…

TuesdayMar 13, 2018 11:00 am

Panhandle Oil and Gas, Inc. (NYSE: PHX) Starts Presentation at 30th Annual ROTH Conference

Panhandle Oil and Gas (NYSE: PHX) is engaged in the exploration for and production of natural gas and oil. The majority of Panhandle Oil and Gas Inc.'s revenues are derived from the production and sale of oil and natural gas. The company's oil and gas holdings, including its 255,000 net mineral acreage and its working interests and royalty interests in producing wells, are primarily located in Arkansas, Oklahoma and Texas. For more information, visit the company’s website at www.panhandleoilandgas.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire…

TuesdayMar 13, 2018 11:00 am

Cronos Group, Inc. (TSX-V: MJN) (PRMCF) Starts Presentation at 30th Annual ROTH Conference

Cronos Group (TSX-V: MJN) (OTC: PRMCF) is a globally diversified and vertically integrated cannabis company operating across four continents. The company runs two wholly-owned Canadian Licensed Producers regulated under Health Canada's Access to Cannabis for Medical Purposes Regulations: Peace Naturals Project Inc. in Ontario, and Original BC Ltd. in British Columbia. Additionally, Cronos has two international production and distribution platforms, Cronos Israel and Cronos Australia. Through an exclusive distribution agreement, Cronos has access to over 12,000 pharmacies in Germany as the company focuses on building an international brand portfolio and developing disruptive intellectual property. For more information, visit the company’s…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Cogentix Medical, Inc. (NASDAQ: CGNT) Starts Presentation at 30th Annual ROTH Conference

PCM, Inc. (NASDAQ: PCMI) Starts Presentation at 30th Annual ROTH Conference

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) Starts Presentation at 30th Annual ROTH Conference

Adesto Technologies Corp. (NASDAQ: IOTS) Starts Presentation at 30th Annual ROTH Conference

Genfit SA (GNFTF) Starts Presentation at 30th Annual ROTH Conference

Vertex Energy, Inc. (NASDAQ: VTNR) Starts Presentation at 30th Annual ROTH Conference

Viking Therapeutics, Inc. (NASDAQ: VKTX) Starts Presentation at 30th Annual ROTH Conference

Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) Starts Presentation at 30th Annual ROTH Conference

Panhandle Oil and Gas, Inc. (NYSE: PHX) Starts Presentation at 30th Annual ROTH Conference

Cronos Group, Inc. (TSX-V: MJN) (PRMCF) Starts Presentation at 30th Annual ROTH Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search